Unlike what another poster wrote, the company does intend to leverage the results in Renevia to the Easthetic market. In fact, at the last conf. call Adi briefed that another trial is being conducted in California where Renevia is being administered to healthy patients for cosmetic purposes.
The logic is simple: the product really works and has much longer lasting results than the alternatives.
So - the product will probably be much better than Botox (when used with fat stem cells). As to its use alone? who knows. it's too early to tell but my gut feeling it will not be worse. and there is not too much cost of goods going into it, so if they decide, they can price it to be competitive against botox. we will see.
Timeline - everything will be in Europe first, and the data and experience will be used to clear with the FDA.
I do not expect it to be a big deal in terms of approval. its really already approved (same content).
There are so many other application for this stuff... They know it and want to keep control so the full spectrum of usage can be established.
But none will happen before next year when marketing starts.
Progress is being made.
We are nearing a point where revenue growth starts, and that is the time when the rest of the market is going to pay attention.
until then, patience is warranted.
